Commonly prescribed psychiatric drugs: do they work?

4932655275_7811863fe8_o

John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.

[read the full story...]

Later menopause linked with lower risk of depression

The menopause is about more than just hot flushes, night sweats and mood swings!

Meg Fluharty summarises a recent systematic review and meta-analysis that looks at the association of age at menopause and duration of reproductive period with depression after menopause.

[read the full story...]

Bariatric surgery can help improve depression, says new meta-analysis

3674894595_637c6cd077_z

Emily Stapley reports on a new JAMA meta-analysis, which finds that mental illnesses such as depression and binge eating disorder are common among patients seeking and undergoing bariatric surgery.

[read the full story...]

Antidepressants: benefits and harms in children and adults

344574172_eaccb04842_o

Samei Huda discusses the findings of a recent review into suicidality and aggression during antidepressant treatment. The systematic review and meta-analyses were based on clinical study reports and included some important adverse effects of antidepressants in children and young people.

[read the full story...]

Which psychotherapies are best for college students with depression?

8548057127_64281ee69f_z

Shirley Reynolds laments the lack of recent high quality evidence, as she reviews a recent meta-analysis of psychological treatment of depression in college students.

[read the full story...]

Aripiprazole for treatment-resistant depression in older adults

16407815325_c4bc936054_k

Sarsha Wilson publishes her debut blog about a recent RCT on the efficacy, safety and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in later life.

[read the full story...]

CBT plus medication for treatment-resistant depression: the CoBalT RCT long-term follow-up

In February 2016 we blogged CoBalT and concluded that CBT plus usual care (including antidepressants) is clinically and cost effective in the long-term for people whose depression has not responded to medication.

Sarah McDonald considers the findings of the CoBalT RCT long-term follow-up, which finds that CBT plus antidepressants are clinically and cost effective for treatment-resistant depression in primary care.

[read the full story...]

Omega-3 fatty acids for depression: Cochrane find insufficient evidence to support use

1816877969_bc1e4ba980_b

Lisa Burscheidt summarises a recent Cochrane systematic review of Omega-3 fatty acids for depression in adults, which finds a lack of evidence to determine the effects of n-3PUFAs as a treatment for major depressive disorder.

[read the full story...]

Are Internet interventions cost-effective for mental health?

16844834832_f13124e85c_o

Chris Sampson looks at a systematic review of the economics of Internet interventions for common mental health problems such as depression and anxiety.

[read the full story...]